171 related articles for article (PubMed ID: 36581325)
1. Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial.
Kim JS; Seo SI; Kang SH; Lee SK; Kim AR; Park HW; Kim BT; Song GS
J Neurogastroenterol Motil; 2023 Jan; 29(1):58-64. PubMed ID: 36581325
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
3. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Johnson DA; Le Moigne A; Hugo V; Nagy P
Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
[TBL] [Abstract][Full Text] [Related]
4. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease.
Kim SH; Cho KB; Chun HJ; Lee SW; Kwon JG; Lee DH; Kim SG; Jung HY; Kim JW; Lee JS; Park H; Choi SC; Jee SR; Kim HS; Ko KH; Park SJ; Lee YC; Park SH; Kim AR; Kim EJ; Park HW; Kim BT; Song GS
Aliment Pharmacol Ther; 2021 Aug; 54(4):402-411. PubMed ID: 34227708
[TBL] [Abstract][Full Text] [Related]
8. Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.
Lee KJ; Son BK; Kim GH; Jung HK; Jung HY; Chung IK; Sung IK; Kim JI; Kim JH; Lee JS; Kwon JG; Park JH; Huh KC; Park KS; Park MI; Kim N; Lee OY; Jee SR; Lee SK; Youn SJ; Kim SK; Lee ST; Hong SJ; Choi SC; Kim TN; Youn YH; Park HJ; Kang MJ; Park CH; Kim BT; Youn S; Song GS; Rhee PL
Aliment Pharmacol Ther; 2019 Apr; 49(7):864-872. PubMed ID: 30843245
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.
Kim BW; Park JJ; Moon HS; Lee WS; Shim KN; Baik GH; Lim YJ; Lee HL; Youn YH; Park JC; Sung IK; Chung H; Moon JS; Kim GH; Hong SJ; Choi HS
Gut Liver; 2024 Mar; 18(2):257-264. PubMed ID: 38384180
[TBL] [Abstract][Full Text] [Related]
10. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease.
Kim DK; Lee KH; Kim SJ; Kim SJ; Lee SJ; Park CH; Kim BT; Song GS; Moon BS; Ryu SY
J Pharmacol Exp Ther; 2019 Jun; 369(3):318-327. PubMed ID: 30894456
[TBL] [Abstract][Full Text] [Related]
11. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
Bayerdörffer E; Bigard MA; Weiss W; Mearin F; Rodrigo L; Dominguez Muñoz JE; Grundling H; Persson T; Svedberg LE; Keeling N; Eklund S
BMC Gastroenterol; 2016 Apr; 16():48. PubMed ID: 27080034
[TBL] [Abstract][Full Text] [Related]
12. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
Jha LK; Fass R; Gadam R; Maradey-Romero C; Nasrollah L; Hershcovici T; Quan SF; Dickman R
J Clin Gastroenterol; 2016 Feb; 50(2):e19-24. PubMed ID: 25887111
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial: A double-blind, proof-of-concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro-esophageal reflux disease and partial response to a healing dose of a proton-pump inhibitor.
Tack J; Vladimirov B; Horny I; Chong CF; Eisner J; Czerniak R; Takanami Y
Neurogastroenterol Motil; 2023 Jan; 35(1):e14468. PubMed ID: 36178335
[TBL] [Abstract][Full Text] [Related]
15. Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.
Yang E; Kim S; Kim B; Kim B; Kim Y; Park SS; Song GS; Yu KS; Jang IJ; Lee S
Br J Clin Pharmacol; 2022 Jul; 88(7):3288-3296. PubMed ID: 35146797
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
Katz PO; Le Moigne A; Pollack C
Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766
[TBL] [Abstract][Full Text] [Related]
18. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
Bytzer P; van Zanten SV; Mattsson H; Wernersson B
Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
[TBL] [Abstract][Full Text] [Related]
19. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J
Scand J Gastroenterol; 2003 Apr; 38(4):347-53. PubMed ID: 12739705
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease.
Park SH; Lee KN; Lee OY; Choi MG; Kim JH; Sung IK; Jang JY; Park KS; Chun HJ; Kim EY; Lee JK; Jang JS; Kim GH; Hong SJ; Lee YC; Choi SC; Kim HS; Kim TO; Baik GH; Jeon YC
Gut Liver; 2023 Mar; 17(2):226-233. PubMed ID: 35730245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]